Neurology

  • Trying to get ahead of Alzheimer disease
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 517-518; DOI: https://doi.org/10.3949/ccjm.87b.09020

    Sorting out patients destined to have Alzheimer disease remains a challenge.

  • 5-Fluorouracil–induced encephalopathy
    Yudai Yano, MD and Akira Kuriyama, MD, MPH
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 532-533; DOI: https://doi.org/10.3949/ccjm.87a.19126

    A woman on chemotherapy for rectal cancer presents with mental status changes.

  • Emerging blood-based biomarkers for Alzheimer disease
    Lynn M. Bekris, PhD and James B. Leverenz, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 537-539; DOI: https://doi.org/10.3949/ccjm.87a.20133

    A blood test for Alzheimer disease could help in drug development and patient care.

  • Medical complications of anorexia nervosa
    CME article
    Jeana Cost, LPC,CEDS, Mori J. Krantz, MD and Philip S. Mehler, MD,FACP,FAED
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 361-366; DOI: https://doi.org/10.3949/ccjm.87a.19084

    Many of these complications resolve with treatment and weight gain, but others can lead to permanent damage.

  • Acute-onset quadriplegia with hyperreflexia
    Nasreen Shaikh, MD, Muhammad Sardar, MD, Wahab Khan, MD and Wael Ghali, MD
    Cleveland Clinic Journal of Medicine January 2019, 86 (1) 7-8; DOI: https://doi.org/10.3949/ccjm.86a.18049

    MRI showed diffuse T2 hyperintensity beginning at the level of the medulla and extending to the level of C7.